Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


Resources

A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Updates

Featured resources and latest news from the Exchanges blog

news

Happy World Vasectomy Day!
World Vasectomy Day, the largest male-oriented family planning event in history, is a social media project that unites men, vasectomy providers and health care activists to increase men’s...
news

NICHD Reissues Funding Call for Contraceptive Research
The Eunice Kennedy Shriver National Institute of Child Health and Human Development has reissued its U-54 funding call to support the scientific agenda of one or two contraceptive research c...
news

Vibliome Therapeutics Wins MCI Research Grant
The Male Contraceptive Initiative (MCI) has awarded Vibliome Therapeutics$500,000 to further develop a non-hormonal male contraceptive lead that prevents sperm from maturing properly.
blog

Hurdles Remain in Quest for New Male Contraceptives
Pharmaceutical companies are not convinced that sales of a new male contraceptive product would offset the cost of Phase III clinical trials, commercialization, and product introduction effo...
event

ESC Call for Research Abstracts
The organizing committee of the 15th Congress of the ESC (European Society of Contraception and Reproductive Health) is calling for abstracts for its May 2018 conference. Submission deadline...
blog

Giving Method Acceptability Research its Due in Contraceptive Dev...
To shed light on the important role method acceptability plays in contraceptive development, the CTI Exchange invited several thought leaders to share their insights in a recently completed ...
news

Newest Awardees of Grand Challenges Explorations Announced
The Bill and Melinda Gates Foundation has announced its newest list of Grand Challenges Explorations grantees. Two of the four Round 18 challenges are of particular interest to contraceptiv...
resource

Calliope, the Contraceptive Pipeline Database
Calliope, the Contraceptive Pipeline Database, provides information on new and future contraceptive products, including long-acting and novel products currently only available in li...
news

NIH to fund Next Generation MPTs
The National Institutes of Health has released a new funding solicitation to support development of the next generation of multipurpose prevention technologies (MPTs). 
blog

Finding an Acceptable, Long-acting, and Reversible Male Contracep...
Even using the conservative modeling estimate of 10% acceptability, a non-hormonal, long-acting, reversible male contraceptive could be a societal game changer.
blog

Through the Eyes of a 16-year-old Zambian Girl
An estimated 33 million female youth do not want to get pregnant but, for one reason or another, are not using modern family planning methods. What can we do to alter this balance sheet?
event

Upcoming Symposium on the Basic Science behind Male Fertility
On October 13, the National Institute of Environmental Health Sciences and the Campion Fund will co-host a 1-day symposium "Advances in Andrology: The Basic Science behind Fertility."

Contribute

We want you to join the exchange!

Contribute

The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback